Bayer Poised To “Seize Opportunities” After Rapid Integration Of Roche OTCs
This article was originally published in The Tan Sheet
Executive Summary
Bayer will continue to pursue external as well as internal growth strategies for its OTC business following the rapid integration of Roche's OTC division